Get the most recent information about COVID-19 from Tufts Health Plan or for more information visit the CDC website.
On April 1, 2020, the FDA announced their request that all manufacturers of ranitidine withdraw all prescription and over the counter (OTC) products from the market immediately. This recall was issued because an unexpected impurity was found in these products that may cause health risks.
For more information or to report any adverse events or quality problems experienced with the use of ranitidine products, please visit the FDA website www.fda.gov.